D
Page may contain affiliate links. Please see terms for details.
OP
OP
Deleted member 6183
Guest
I was talking to a lady today who's 40 year old daughter died of cancer and is being buried on Friday, that'll put a downer on Christmas.
MancMike
New Member
- Joined
- Jul 29, 2014
- Messages
- 0
Meanwhile in Salford, I think that story has to top them all for ruined Christmases. :'(
OP
OP
Deleted member 113659
Guest
Yeah. Terrible news that Mike. RIP poor little souls.
It doesn't remotely compare to some of the things already mentioned but we had a power failure one Christmas day which meant no heating in the house and no cooking facilities. Another year the heating element in the oven failed on Christmas morning which left us cooking in a microwave. You improvise and survive. Christmas day could get boring if it was always the same.
grober
MB Master
It's easy to focus on the negative but this week may be when a significant step forward was announced in the treatment of Hungtington's Chorea Its easy to write this off as a non-story but the Swiss pharmaceutical giant Roche has paid a $45m licence fee to take the drug forward to clinical use. The drug, developed by the California biotech firm Ionis Pharmaceuticals, is a synthetic single strand of DNA customised to latch onto the huntington messenger molecule produced by a harmful genetic mutation in suffers of the condition. Perhaps even more exciting is the potential this customisable biopharmaceutical has to slow or prevent other neurodegenerative diseases such as Altzeimers.
Woody would have appreciated it.
Excitement as trial shows Huntington's drug could slow progress of disease
Huntington's disease - Wikipedia
Woody would have appreciated it.
Excitement as trial shows Huntington's drug could slow progress of disease
Huntington's disease - Wikipedia
Martin 1
Active Member
- Joined
- Mar 9, 2017
- Messages
- 898
- Location
- Northants
- Car
- '05 CLK 200 auto Convertible. silver with blue hood.
It's easy to focus on the negative but this week may be when a significant step forward was announced in the treatment of Hungtington's Chorea Its easy to write this off as a non-story but the Swiss pharmaceutical giant Roche has paid a $45m licence fee to take the drug forward to clinical use. The drug, developed by the California biotech firm Ionis Pharmaceuticals, is a synthetic single strand of DNA customised to latch onto the huntington messenger molecule produced by a harmful genetic mutation in suffers of the condition. Perhaps even more exciting is the potential this customisable biopharmaceutical has to slow or prevent other neurodegenerative diseases such as Altzeimers.
Woody would have appreciated it.
Excitement as trial shows Huntington's drug could slow progress of disease
Huntington's disease - Wikipedia
Best news of all mate, let's hope it happens quickly !
